ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas

Oral Diseases

Volumn 16, Issue 8, 2010, Pages 774-780

  Silva, S D ^a   Cunha, I W ^a   Younes, R N ^a   Soares, F A ^a   Kowalski, L P ^a   Graner, E ^b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

ErbB receptors; Fatty acid synthase; Head and neck squamous cell carcinomas; Metastatic tumors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID SYNTHASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADULT; AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FATTY ACID SYNTHETASE COMPLEX, TYPE I; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE;

EID: 77958164682     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01687.x     Document Type: Article

References (40)

1. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U (1996). Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77: 474-482.
2. Alo PL, Visca P, Trombetta G et al (1999). Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 85: 35-40.
3. Alo PL, Visca P, Framarino ML et al (2000). Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 7: 1383-1388.
4. Baron A, Migita T, Tang D, Loda M (2004). Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91: 47-53.
5. Casalini P, Iorio MV, Galmozzi E, Ménard S (2004). Role of HER receptors family in development and differentiation. J Cell Physiol 200: 343-350.
6. Cheng CM, Tsuneyama K, Matsui K, Takahashi H, Ishizawa S, Takano Y (2005). Cytoplasmic expression of c-erbB2 in non-small cell lung cancers. Virchows Arch 446: 596-603.
7. Curado MP, Hashibe M (2009). Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21: 194-200.
8. Ferretti G, Felici A, Papaldo P, Fabi A, Cognetti F (2007). HER2/neu role in breast cancer: from a prognostic foe to a predictive friend. Curr Opin Obstet Gynecol 19: 56-62.
9. Gabrielson EW, Pinn ML, Testa JR, Kuhajda FP (2001). Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 7: 153-157.
10. Gansler TS, Hardman W III, Hunt DA, Schaffel S, Hennigar RA (1997). Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28: 686-692.
11. Gusterson BA, Guillick WJ, Vener DJ et al (1987). Immunohistochemical localization of c-erbB-2 in human breast carcinomas. Br J Cancer 58: 453-457.
12. Hardisson D (2003). Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260: 502-508.
13. Holbro T, Civenni G, Hynes NE (2003). The ErbB receptors and their role in cancer progression. Exp Cell Res 284: 99-110.
14. Jayakumar A, Tai MH, Huang WY et al (1995). Human fatty acid synthase: properties and molecular cloning. Proc Natl Acad Sci USA 92: 8695-8699.
15. Kassouf W, Black PC, Tuziak T et al (2008). Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer. J Urol 179: 353-358.
16. Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF Jr, Magrin J (2000). Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 22: 207-214.
17. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM (2003). Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63: 132-139.
18. Lafky JM, Wilken JA, Baron AT, Maihle NJ (2008). Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 1785: 232-265.
19. Menendez JA, Vellon L, Mehmi I et al (2004). Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci USA 101: 10715-10720.
20. Menendez JA, Lupu R, Colomer R (2005). Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Drug News Perspect 18: 375-385.
21. O-charoenrat P, Rhys-Evans P, Eccles S (2000). Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells. Int J Cancer 88: 759-765.
22. O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA (2002). The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 38: 627-640.
23. Penuel E, Schaefer G, Akita RW, Sliwkowski MX (2001). Structural requirements for ErbB2 transactivation. Semin Oncol 28(6 Suppl. 18): 36-42.
24. Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS, Nelson JB (2001). Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 47: 102-110.
25. Press MF, Hung G, Godolphin W, Slamon DJ (1994). Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54: 2771-2777.
26. Pu J, McCaig CD, Cao L, Zhao Z, Segall JE, Zhao M (2007). EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells. J Cell Sci 120 (Pt 19): 3395-3403.
27. Roskoski R Jr (2004). The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 319: 1-11.
28. Silva SD, Agostini M, Nishimoto IN et al (2004). Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncol 40: 688-696.
29. Silva SD, Cunha IW, Rangel AL et al (2008). Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes. Virchows Arch 453: 57-67.
30. Silva SD, Cunha IW, Nishimoto IN et al (2009). Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol 45: 134-139.
31. Stein RA, Staros JV (2006). Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis. BMC Evol Biol 6: 79.
32. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G (1997). Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res 57: 1086-1090.
33. Syrigos KN, Zalonis A, Kotteas E, Saif MW (2008). Targeted therapy for oesophageal cancer: an overview. Cancer Metastasis Rev 27: 273-288.
34. Wahi PN, Cohen B, Luthra UK, Torloni H (1971). Histological typing of oral and oropharyngeal tumours. Geneva: World Health Organization. 28
35. Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J (2008). EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases. Ann Surg Oncol 15: 1193-1201.
36. Younes RN, Gross JL, Silva JF, Fernandez JA, Kowalski LP (1997). Surgical treatment of lung metastases of head and neck tumors. Am J Surg 174: 499-502.
37. Zeren T, Inan S, Seda Vatansever H, Ekerbicer N, Sayhan S (2008). Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha. Acta Histochem 110: 256-263.
38. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES (2005). Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 4: 1686-1696.
39. Zhang H, Berezov A, Wang Q et al (2007). ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117: 2051-2058.
40. Zhou X, Temam S, Oh M et al (2006). Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8: 925-932.